Apollo Hospitals Partners with Solventum to Enhance AI-Powered Cardiovascular Disease Risk Tool
What’s the News?
Apollo Hospitals, one of India’s largest hospital chains, has partnered with Solventum Health Information Systems to develop its AI-powered Cardiovascular Disease Risk tool. This collaboration aims to improve the tool’s accuracy in predicting cardiovascular disease risks and reducing hospital stays and complications.
Why is this Important?
Cardiovascular diseases are the leading causes of premature death and morbidity in India, accounting for over a quarter of deaths in the country. With a severe cardiologist shortage, the use of predictive analytics is crucial in bridging this gap. This partnership will help identify patients at high risk of adverse outcomes and improve patient outcomes, access, and operational efficiency.
The Project
The collaboration will integrate Solventum’s patient classification and quality methodologies with Apollo’s AI-powered Cardiovascular Disease Risk technology. They will assess the effectiveness of their combined solution on population health and resource efficiency metrics, including mortality, lengths of stay, complications, and readmissions.
How will it Work?
The project will evaluate opportunities to deliver high-quality care in the most cost-effective way by leveraging diagnosis-related groups, case mix index, and severity of illness. It will also focus on increasing resource utilization efficiency.
Background
Apollo introduced its Cardiovascular Disease Risk tool in 2021, built using data from over 400,000 patients. The tool takes into account lifestyle attributes and vital signs to predict an individual’s risk of cardiovascular diseases. The tool was later integrated into ConnectedLife, a healthcare application and Fitbit partner in Singapore.
What’s Next?
The partnership will continue to develop the AI-powered Cardiovascular Disease Risk tool, with plans to adopt AI copilots from Microsoft as part of a new partnership to support its AI roadmap implementation.
On the Record
"This powerful union enables us to pinpoint high-risk patients more accurately and deliver timely, personalized care. This breakthrough is leading to a dramatic reduction in complications and hospital stays while fundamentally transforming patient outcomes and broadening access to high-quality care every individual deserves," said Dr. Sangita Reddy, co-managing director of Apollo Hospitals.
"We believe this collaboration can help us more accurately identify patients who are at high risk of adverse outcomes that may need additional services. We anticipate improved patient access, operational efficiency, and clinical outcomes as a result of our joint efforts," added Dr. Sandeep Wadhwa, global chief medical officer at Solventum HIS.
Conclusion
This partnership between Apollo Hospitals and Solventum Health Information Systems has the potential to revolutionize cardiovascular care in India. By combining their expertise in predictive analytics, they can improve patient outcomes, access, and operational efficiency. This is an exciting development in the field of healthcare, and we can expect to see significant improvements in the years to come.
Frequently Asked Questions
- What is the purpose of the partnership?
The partnership aims to develop and improve Apollo’s AI-powered Cardiovascular Disease Risk tool. - What are the goals of the project?
The project aims to evaluate opportunities to deliver high-quality care in the most cost-effective way and to increase resource utilization efficiency. - What is the significance of this partnership?
The partnership is crucial in addressing the severe cardiologist shortage in India and improving patient outcomes, access, and operational efficiency.
